Innovating to drive sustainable Beauty - GEKA releases its first Sustainability Report
July 05, 2022
As a part of medmix, a global leader in high-precision delivery devices, GEKA (medmix Beauty) is releasing its first Sustainability report, outlining the commitment to and progress towards the company’s sustainability goals.
The reduction of the carbon footprint of its global value chain is one of the key targets discussed in the report – with the medmix objective of achieving a 30% reduction compared to 2019, in addition to securing at least “B” ranking from CDP.
On this target, GEKA has already secured a B ranking from CDP and has decreased overall carbon footprint by 13.2% compared to 2019. It is on track to achieve the 30% reduction target objective by 2025.
“At medmix our mission is to provide innovative solutions that help millions of people live healthier and more confident lives. Our commitment to sustainability remains at the forefront of our business agenda. With GEKA as a market-leader in cosmetic applicators and packaging solutions, we drive the development of sustainable Beauty,” says Girts Cimermans, CEO of medmix. “I am proud of the programs and initiatives discussed in this report, and I am excited by what lies ahead, as we continue delivering on our sustainability strategy.”
GEKA takes a systematic approach, working closely with its’ stakeholders across the value chain, suppliers, employees, communities, and customers to develop and deliver solutions that drive meaningful, long-lasting, and positive change.
Download GEKA’s Sustainability Report here:
Founded in 1925, the GEKA brand is a world leading manufacturer, supplier and wholesaler for high precision beauty application solutions for mascara, lip gloss and concealer products. With deep expertise in beauty tools, twisted wire brush and micro brush technologies GEKA represents continuous innovation through its numerous patents. As part of medmix, a global provider of high precision delivery devices, GEKA offers worldwide access through manufacturing sites in Bechhofen, Germany, Elgin, USA, Sao Paulo, Brazil, and Shanghai, China.
medmix is a global leader in high-precision delivery devices. We occupy leading positions in the healthcare, consumer and industrial end-markets. Our customers benefit from a dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 13 production sites worldwide together with our highly motivated and experienced team of 1’900 employees provide our customers with uncompromising quality, proximity and agility. medmix is currently headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX).
Media Relations: Domenico Truncellito, Head External Communications
Investor Relations: Christoph Ladner, Head of Investor Relations
This document may contain forward-looking statements including, but not limited to, projections of financial developments, market activity, or future performance of products and solutions containing risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors that could cause actual results or performance to differ materially from the statements made herein.